Synthesis and biological activity of novel potent endothelin-converting enzyme-1 inhibitors

被引：12
作者：
Firooznia, F [1 ]
Gude, C [1 ]
Chan, K [1 ]
Fink, CA [1 ]
Qiao, Y [1 ]
Satoh, Y [1 ]
Marcopoulos, N [1 ]
Savage, P [1 ]
Beil, ME [1 ]
Bruseo, CW [1 ]
Trapani, AJ [1 ]
Jeng, AY [1 ]
机构：
[1] Novartis Inst Biomed Res, Summit, NJ 07901 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2001年 / 11卷 / 03期
关键词：
D O I：
10.1016/S0960-894X(00)00657-0
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Through directed screening of metalloprotease inhibitors. CGS 30084 (1) has been identified as a potent endothelin-converting enzyme-1 (ECE-1) inhibitor in vitro (IC50 = 77 nM). Herein we report the synthesis and biological activities of analogues derived from this lead. based on modifications of the biphenyl moiety. Compound 10. the thioacetate methyl ester prodrug derivative of compound 6m. was found to he an orally active and potent inhibitor of ECE-1 activity in rats. (C) 2001 Elsevier science Ltd. All rights reserved.
引用
收藏
页码：375 / 378
页数：4
相关论文
共 50 条
  • [31] Expression and localization of endothelin-converting enzyme-1 in human prostate cancer
    Dawson, Louise A.
    Maitland, Norman J.
    Berry, Paul
    Turner, Anthony J.
    Usmani, Badar A.
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2006, 231 (06) : 1106 - 1110
  • [32] Endothelin-converting enzyme-1 degrades internalized somatostatin-14
    Roosterman, Dirk
    Kempkes, Cordula
    Cottrell, Graeme S.
    Padilla, Benjamin E.
    Bunnett, Nigel W.
    Turck, Christoph W.
    Steinhoff, Martin
    ENDOCRINOLOGY, 2008, 149 (05) : 2200 - 2207
  • [33] Hydrolysis of peptide hormones by endothelin-converting enzyme-1 - A comparison with neprilysin
    Johnson, GD
    Stevenson, T
    Ahn, KH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (07) : 4053 - 4058
  • [34] Induction of endothelin-converting enzyme-1 in gastric mucosal injury by idomethacin
    Slomiany, BL
    Slomiany, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 269 (02) : 377 - 381
  • [35] Characterization of human endothelin-converting enzyme-1 cellular distribution.
    Pinet, F
    Korth, P
    Bohle, RM
    Corvol, P
    HYPERTENSION, 1998, 32 (04) : 795 - 795
  • [36] Distribution of endothelin-converting enzyme-1 and neutral endopeptidase in human endometrium
    Iwase, Akira
    Ando, Hisao
    Nagasaka, Tetsuro
    Goto, Maki
    Harata, Toko
    Kikkawa, Fumitaka
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2007, 55 (12) : 1229 - 1235
  • [37] Thiol inhibitors of endothelin-converting enzyme
    Deprez, P
    Guillaume, J
    Dumas, J
    Vevert, JP
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (19) : 2317 - 2322
  • [38] Endothelin-converting enzyme-1 inhibition and growth of human glioblastoma cells
    Berger, Y
    Delmilow, HI
    Blum-Kaelin, D
    Kitas, EA
    Löffler, BM
    Aebi, JD
    Juillerat-Jeanneret, L
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (02) : 483 - 498
  • [39] Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis
    Ihling, C
    Szombathy, T
    Bohrmann, B
    Brockhaus, M
    Schaefer, HE
    Loeffler, BM
    CIRCULATION, 2001, 104 (08) : 864 - 869
  • [40] Coexpression of endothelin-converting enzyme-1 and endothelin-1 in early stages of human atherosclerosis
    Ihling, C
    Szombathy, T
    Schaefer, HE
    Brockhaus, M
    Loeffler, BM
    La Roche, H
    CIRCULATION, 1999, 100 (18) : 474 - 474
12345